Abbott starts Absorb Japan trial in CAD patients
Japan | News | By BioSpectrum Bureau | 0 Comment | 13 Jun, 2013
Singapore: Abbott announced that it has initiated the Absorb Japan randomized controlled clinical trial to evaluate the ...Read more
Chugai seeks nod for breast cancer drug in Japan
Japan | News | By BioSpectrum Bureau | 0 Comment | 01 Feb, 2013
Singapore: Japanese multinational Chugai Pharmaceutical has filed a new drug application to the Ministry of Health, Labo...Read more
Japanese stem cell researcher wins 2012 Nobel in medicine
Japan | News | By BioSpectrum Bureau | 0 Comment | 08 Oct, 2012
Singapore: Dr Shinya Yamanaka, director of the Center for iPS Cell Research and Application (CiRA), Kyoto University, ha...Read more
Chugai Pharma appoints new CMO
Japan | News | By BioSpectrum Bureau | 0 Comment | 29 Apr, 2014
Singapore: Chugai Pharma USA, Berkeley Heights, NJ a wholly owned subsidiary of Chugai Pharmaceutical, Tokyo, Japan, mem...Read more
Japan to host its first-ever medicine expo in 2014
Japan | News | By BioSpectrum Bureau | 0 Comment | 20 Sep, 2013
Singapore: Japan is hosting its first personalised medicine and diagnostics expo in May 14-16, 2014.The Japanese governm...Read more
Medical devices: A hot segment in Japan
Japan | Analysis | By BioSpectrum Bureau | 0 Comment | 01 Jun, 2012
The aging population in Japan is not only driving the medical care and pharmaceutical industry but also the medical devi...Read more
Eisai's Halaven now available in Spain
Japan | News | By BioSpectrum Bureau | 0 Comment | 05 Sep, 2013
Singapore: Eribulin, an anticancer drug marketed by Japan-based Eisai under the trade name Halaven, has received reimbur...Read more
Europe to get new epilepsy drug from Eisai
Japan | News | By BioSpectrum Bureau | 0 Comment | 13 Sep, 2012
Singapore: Eisai has decided to launch its AMPA receptor antagonist Fycompa (perampanel), a first-in-class anti-epilepti...Read more
What are the hurdles before stem cell research?
Japan | Analysis | By Piyusha Chatterjee | 2 Comment | 31 Jan, 2013
The pioneering research of Nobel Laureates Sir John Gurdon and Dr Shinya Yamanaka on reprogramming adult stem cells has ...Read more
Takeda R&D filed 7 NDAs in the last 8 months
Japan | News | By BioSpectrum Bureau | 0 Comment | 05 Oct, 2012
Singapore: Takeda Global Research and Development, a wholly owned subsidiary of Takeda Pharmaceutical, has filed seven n...Read more
US FDA's Priority Review Status for Takeda's IND
Japan | Regulatory | By BioSpectrum Bureau | 0 Comment | 05 Sep, 2013
Singapore: Takeda Pharmaceutical and its wholly-owned subsidiary, Takeda Pharmaceuticals USA, have announced that the US...Read more
India invites Japanese firms to invest in healthcare
Japan | News | By BioSpectrum Bureau | 0 Comment | 07 Oct, 2013
New Delhi: Aiming at becoming one of the global manufacturing hubs, besides being a large healthcare market, India has i...Read more
BS Survey: Healthcare is getting smarter in Asia
Japan | Analysis | By BioSpectrum Bureau | 0 Comment | 30 Nov, 2012
...Read more
Japan's top 5 bio firms fund $100 mn HIV, TB research
Japan | News | By BioSpectrum Bureau | 0 Comment | 30 May, 2013
Singapore: Japan's top pharma companies, including Astellas, Eisai, Daiichi Sankyo, Shionogi, and Takeda, have come toge...Read more
Eisai gets WHO prequalification, will donate 2.2 bn doses
Japan | News | By BioSpectrum Bureau | 0 Comment | 03 Sep, 2013
Singapore: The WHO has prequalified Eisai's drug NTD002, a 100 mg tablet of diethylcarbamazine (DEC) for treatment of el...Read more
BSA-CMR Survey: APAC CROs stick to an average of 50 clients
Japan | Analysis | By BioSpectrum Bureau | 2 Comment | 18 Sep, 2013
The fifth edition of the annual BioSpectrum Asia Pacific clinical research organization (CRO) Survey, which is conduct...Read more
Sysmex wins performance award in the US
Japan | News | By BioSpectrum Bureau | 0 Comment | 13 Jun, 2012
Singapore: The wholly-owned US subsidiary of Sysmex, Sysmex America, has won the seventh annual Pinnacle Award presented...Read more
Solasia appoints Yoshihiro Arai as president
Japan | News | By BioSpectrum Bureau | 0 Comment | 07 Feb, 2013
Singapore: Mr Yoshihiro Arai, currently general manager and head of development of Solasia Pharma, has been promoted to...Read more